Gain the Decision Advantage
Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.
A versatile Clinical Trial Management Solution, LifeSphere® CTMS10 contains great functionality and five key benefits, addressing a variety of challenges in the clinical product lifecycle.
This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.
On June 16th, 2020, ArisGlobal participated in the 2020 DIA ...
ArisGlobal, part of the more cautious and highly regulated life science go “all-in on AWS” by moving the entire cloud infrastructure to the AWS platform. This move benefits both ArisGlobal and to our customers.
LifeSphere® Safety MultiVigilance is the only E2B R3 compliant multi-tenant ...
On May 14, 2020, ArisGlobal hosted a webinar titled Regulatory ...
Many life sciences companies are still utilizing a manual process for their medical affairs needs. ArisGlobal’s LifeSphere ® Medical Affairs platform can help automate this process. Learn more about Medical Affairs and automated processes with our webinar, Optimizing Adverse Event Reconciliation in Medical Affairs.
This is the fourth in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety business units at ArisGlobal. Director of Product Management – Medical Affairs and Quality, Sandeep Mahagaonkar, spoke about what attracted him to ArisGlobal, the state of Medical Affairs, and the vision for 2020 and beyond.
This is the first in a four-part blog series that examines the Clinical, Medical Affairs, Regulatory, and Safety product domains at ArisGlobal. Senior Director of Clinical Product Management, Sondra Pepe, describes what attracted her to ArisGlobal and articulated the vision for Clinical product strategy.
On May 19th and 20th, pharmacovigilance leaders from across the ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved